applying the term EMT to tumor progression. Based on clinical observations, it is more appropriate in most cases to describe the emergence of an "EMT-like" phenotype during tumor progression. This does not imply complete trans-differentiation but emphasizes the intermediary phenotype associated with tumor cell renewal and adaptation to specific microenvironments.
Here, we categorize the various EMT-like phenotypes found in human carcinomas that, depending on the tumor type, may or not represent analogous stages in tumor progression. We based these categories on global tumor phenotype. Tumor microenvironment associated with stromal reactions, hypoxia, paucity of nutrients, impaired differentiation and that activation of various EMT-associated pathways, modulate overall tumor phenotype and lead to tumor heterogeneity.
The epithelial-mesenchymal transition concept: Epithelial-mesenchymal transition (EMT) describes a rapid and often reversible change of cell phenotype. EMT was originally defined in the context of cellular remodeling that occurs during heart morphogenesis 1 , and has been applied to a range of events, including mesoderm and neural crest formation 2 . The reverse process, mesenchymal-epithelial transition also occurs during development 3 . During EMT, epithelial 9/12/08 4 cells loosen their characteristic cell-cell adhesion structures, change their polarity, modulate the organization of their cytoskeletal systems, switch expression from keratin-to vimentin-type intermediate filaments, and become isolated, motile, and resistant to anoikis 4 5 .
EMT bears at least a superficial resemblance to the steps in the transition of normal to metastatic cells during epithelial tumor progression. That the concept of EMT was relevant to tumor progression was refined and explored in vitro, most notably by E.D. Hay, using epithelial cell models; these cells could be transformed into individualized motile cells through manipulations using growth factors or extracellular matrix components 6 . Original EMT models include the transformation of lens epithelial cells growing in collagen gels 7 , NBT-II carcinoma cells responding to fibroblast growth factor (FGF) 8 and MDCK cells responding to hepatocyte growth factor/scatter factor (HGF/SF) [9] [10] [11] . Over the years, many more models have been described, and a number of genes have been implicated in EMT-like behavior of tumor cell 12 
.
As is often the case, genes active (and activated) during the course of carcinoma progression and metastasis are also active in other processes, specifically during early embryogenesis, tissue morphogenesis, wound healing 2, [13] [14] [15] . This has lead to the idea that EMT, as it occurs in the course of developmental events, is "reactivated" during tumor progression. The popularity of this idea is suggested by the fact that a recent search on "epithelial-mesenchymal transition" and "cancer" using PubMed (NCBI, NIH) yielded more than 463 references. On the other hand, the assumption that EMT is actually relevant to cancer progression has raised serious objections from pathologists who points out the lack of direct clinical evidence for EMT 16 . A re-evaluation of the literature suggests that there are good reasons to make a clear distinction between EMT senso stricto and the EMT-like phenotype observed in carcinoma. 14 . The loss of cell-cell adhesion, however, does not make an EMT! Perhaps the major obstacle in identifying EMT-specific events is the lack of definitive markers for post-EMT cells.
For example keratin expression is routinely used by pathologists to identify epithelial-derived carcinoma cells 17 , but cannot be used to identifying post-EMT cells since these cells should (if an actual EMT event were taking place) no longer express keratin. In fact, post-EMT epithelial cells will be phenotypically similar to (normal) vimentin-expressing stromal cells. Several groups have attempted to decipher the clonal origins of epithelial and mesenchymal components of tumors by comparative genotypic analysis using microsatellite markers [22] [23] [24] [25] . In fact, some less common tumors such as phyllodes tumors of the prostate were found to combine stromal and epithelial components with distinct clonal origins 18 . However, this strategy has been problematic when applied to more prevalent mammary invasive ductal carcinomas: transformed stroma cells share chromosomal rearrangements with transformed epithelial cells, suggesting common origin, but also contain stroma specific rearrangements [19] [20] [21] . A clearer situation is found in carcinosarcoma, rare tumors mostly described in uterus and lung, that display a mix of epithelial and mesenchymal cell types. Most studies indicate that these tumors are derived from a common epithelial progenitor that gives rise to a mesenchymal subpopulation presumably through an EMT-like process.
"EMT-like" phenotypes in cancer:
There is an important distinction to make based on the poorly differentiated state of many carcinoma cells. Their phenotype may reflect a dedifferentiation rather than a trans-differentiation process, such as occurs during EMT. From 9/12/08 6 this perspective, transformed epithelial progenitors/stem cells may simply fail to differentiate normally, rather than differentiate into mesenchymal cells. If this is the case, the use of the term EMT is inappropriate and confusing, since it is misleading about the origin of the cells (Fig. 1 ).
To address this issue, we suggest using the term "EMT-like" as a more descriptive and accurate term to describe the phenotypes of epithelial cancers, since it does not imply a specific mechanism or the origin of the cells described. We propose three functional criteria to define Considering the phenotypic heterogeneity of most human tumors, this classification does not preclude that some tumor area may show distinct phenotypic features. That said, most tumors do display a dominant phenotype which is used by pathologist for typing. Applying this scheme to human carcinoma types we have evaluated all major human carcinoma types, based on reference works 26, 27 , original articles [28] [29] [30] , and our personal observations on breast and colon carcinomas typed and identified by the pathology department at CRLC Val d'Aurelle 9/12/08 7 (Montpellier, France)( Table 1) . Some of the criteria we are suggesting here for "EMT-like" phenotyping are used in routine by pathologists. For example, expression of E-cadherin, a major player in epithelial cell-cell adhesion, is used to differentiate breast invasive ductal carcinoma which express E-cadherin protein and invasive lobular carcinoma that do not 31, 32 . In summary, there are limited but therapeutically significant numbers of carcinomas with phenotypes 2 and 3,
involving poorly differentiated cells that may remain partially cohesive.
EMT-like behavior and tumor heterogeneity: Typically, most carcinomas display histological heterogeneity. We and others . Recently, work from R. Weinberg's laboratory has emphasized molecular links between EMT process and emergence of "stemness" 40 . This is interesting because stemness is distinct from mesenchymal behavior.
Epithelial cells initiate migration by becoming "activated". Activation is considered a "metastable phenotype" 41 that combines incomplete differentiation, cell motility and some cellcell cohesiveness. It can be considered "EMT-like". For example, during wound healing, appear to control EMT-like phenotypes and tumor metastasis in mouse models 13, 14 . The on-set of both EMT and EMT-like events are associated with loss of cellular polarity, partial to total destabilization of cell-cell junctions, remodeling and replacement 9/12/08 9 of cytoskeletal components, the onset of cell motility and the suppression of apoptosis.
Transcriptional down regulation of junctional components accompanies the EMT process in several systems 13, 48 and may be the cause or an effect of EMT-like events.
Down-regulation of E-cadherin is linked to cell-cell dissociation and invasion in pancreas, prostate and mammary gland mouse cancer models 49, 50 . Specific transcription factors, in particular Snail (Snail1), Slug (Snail2), Twist, SIP1/Zeb and E47, negatively regulate E-cadherin expression 51, 52 , and presumably display overlapping functional redundancy, in part through their common recognition of E-box sequences. These factors appear to be involved in most physiological EMT situations. Their over-expression in epithelial cell lines usually induces an EMT 48, [51] [52] [53] . However, their specificity is clearly not restricted to E-cadherin regulation and EMT process. For example, members of the Snail family have been shown to be involved in cell motility, proliferation control, differentiation and apoptotic regulation in vivo and in cell models [54] [55] [56] [57] [58] [59] . At the same time, detailed mechanism(s) of their effects remain unclear since cellular coexpression of Snail and E-cadherin has been described in breast and colon carcinomas by several groups 33, 60 .
Distinct pathways inducing EMT have been uncovered recently, emphasizing functional links between EMT-like phenotypes and inductive pathways specifically activated during tumor growth and progression (Fig. 2) . Tumor cell growth requires an increase in local vasculature to provide metabolites and oxygen. Cells adjust to a nutritionally impoverished and hypoxic environment by activating specific pathways, associated with hypermetabolism 61 , glycolysis and resistance to acidosis-induced toxicity, and neoangiogenesis. Hypoxia genes have been found to be expressed locally within solid tumors, probably contributing to tumor heterogeneity 62 . The link between hypoxia and EMT has been recently strengthened by the observed activation of Snail and Twist expression by HIF-1, a key hypoxia effector [63] [64] [65] . Another hypoxia-related gene, 9/12/08 10 lysyl oxydase, was found to interact directly with Snail, but the functional significance of this interaction has been disputed 66, 67 .
Another specific feature of tumor microenvironment is the stromal reaction through which epithelial-mesenchymal interactions activate or regulate several pathways involving integrins, cytokines and growth factors that are critical for tumor growth and metastasis In both situations, tumor microenvironment controls cell phenotype through several tumorspecific pathways being investigated. 
